Bacil Pharma LtdBSE: BACPHAR

Intimation Regarding Execution Of Agreement By Wholly Owned Subsidiary Of The Company

· Issued by Bacil Pharma Ltd via BSE India

Filed with BSE · · 2 pages · English

Summary by 6ix AI

The project will focus on developing various pharmaceutical forms, including pellets, granules, powders, tablets, and capsules. The estimated cost for this project is significant, and Mrs. Chaitali Shah has been authorized to execute the agreement and manage related activities.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Bacil Pharma Ltd on 6ix

Earlier from Bacil Pharma

All Bacil Pharma news releases